[Washington, D.C., August 9, 2023] – Viscadia, a leading life sciences forecasting firm, is pleased to announce the appointment of Douglas H. Willson, Ph.D., as Principal, contributing to the continuous enhancement of the company’s industry-leading capabilities in delivering accurate and actionable forecasts.

With a career spanning over 20 years, Willson brings extensive experience and expertise in life sciences forecasting, market research, and strategic planning to Viscadia. His appointment reflects Viscadia’s commitment to providing clients with cutting-edge solutions and insights to navigate the complexities of the pharmaceutical landscape.

Willson has held senior leadership positions at global organizations such as Ipsos Healthcare Advisory Services, Cello Health Advantage, ZS Associates, A+A Bell Falla/Bell Falla and Associates, GfK Healthcare, and National Analysts Inc. (now Naxion). Throughout his career, he has led forecasting practices, driven innovation in market research methodologies, and spearheaded numerous successful forecasting engagements for pharmaceuticals, biologics, medical devices, and diagnostics.

“We are thrilled to welcome Doug to Viscadia,” said Satish K. Kauta, Founder and CEO of Viscadia. “Building on his extensive knowledge, we aim to maintain our commitment to providing gold-standard services and solidifying our position as a premier life sciences forecasting firm.”

In his role as Principal at Viscadia, Willson will provide strategic guidance, lead forecasting initiatives, and leverage his vast experience to drive innovation and confidence in life science forecasting.

“I am excited to join Viscadia and contribute to their mission of empowering clients with accurate and actionable forecasts,” said Willson. “Viscadia’s commitment to excellence, innovation, and client-centric focus align perfectly with my own professional values. I look forward to collaborating with the exceptional team at Viscadia and delivering outstanding forecasting solutions to our clients.”

With the appointment of Douglas H. Willson, Ph.D., Viscadia solidifies its standing as a leading provider of forecasting solutions in the life sciences industry. Through a combination of advanced analytics, cutting-edge technologies, and a team of seasoned professionals, Viscadia continues to set new standards in delivering accurate and actionable forecasts to drive informed decision-making.